世界の経腸栄養剤市場2021-2028:製品別、フロータイプ別、段階別(成人、小児)、疾患別、エンドユーザー別、地域別

◆英語タイトル:Enteral Feeding Formulas Market Size, Share & Trends Analysis Report By Product, By Flow Type, By Stage (Adult, Pediatric), By Indication, By End-user, By Region, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MA048
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年2月26日
◆ページ数:118
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥678,300見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥792,300見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,020,300見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の経腸栄養剤市場規模が2028年までに93憶ドルに達すると予測しています。2021年から2028年までに年平均5.9%成長する見通しです。本調査レポートでは、経腸栄養剤の世界市場について広く調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、競争分析、製品別(標準栄養剤、疾患特定栄養剤)分析、フロータイプ別(断続投与、連続投与)分析、段階別(成人、小児)分析、疾患別(アルツハイマー病、栄養不足、癌、糖尿病、慢性腎臓病)分析、地域別分析、競争状況など、以下の構成でまとめております。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・競争分析
・経腸栄養剤の世界市場規模:製品別(標準栄養剤、疾患特定栄養剤)
・経腸栄養剤の世界市場規模:フロータイプ別(断続投与、連続投与)
・経腸栄養剤の世界市場規模:段階別(成人、小児)
・経腸栄養剤の世界市場規模:疾患別(アルツハイマー病、栄養不足、癌、糖尿病、慢性腎臓病)
・経腸栄養剤の世界市場規模:地域別
・競争状況
【レポートの概要】

Enteral Feeding Formulas Market Growth & Trends

The global enteral feeding formulas market size is expected to reach USD 9.3 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 5.9% from 2021 to 2028. The growing prevalence of chronic diseases such as cancer, stroke, multiple sclerosis, dementia, chronic liver disease, Chronic Obstructive Pulmonary Disease (COPD), and diabetes is projected to drive the demand for products that support patients with oral intake issues. In addition, the rise in preterm births is one of the significant factors boosting the demand for enteral feeding formulas to meet the nutritional requirements of newborns.

Based on product, the standard formulas segment dominated the market and accounted for the largest revenue share of 54.0% in 2020. This high share is attributable to the availability of a vast variety of standard formulas coupled with increased demand for low-cost nutrient formulations. In addition, the demand with respect to standard tube feeds is significant among the volume-sensitive patients or the patients on fluid restrictions. Such conditions include renal failure, congestive heart failure, and Syndrome of Inappropriate Antidiuretic Hormone (SIADH).

In 2020, based on flow type, the intermittent feeding flow type segment accounted for the highest revenue share in the market because intermittent feeding has shown better tolerance in patients as compared to bolus feeding. Moreover, this type of feeding does not require feeding pumps, which is helpful in allowing greater mobility in between the feedings. This is expected to increase its adoption among the hospital as well as homecare settings, thereby affirmatively impacting the segment growth.

In 2020, based on stage, the adults’ segment accounted for the highest revenue share of 88.4% in the market. The segment is projected to witness the fastest CAGR over the forecast period. The rising adoption of tube feeds in adults is one of the crucial factors driving the growth. In addition, the availability of large number of tube feeds or products for adults on a commercial level also contributes to the large share held by the segment. Glucerna, Osmolite, TwoCal, Vital, Promote, and Jevity are some of the popular brands by Abbott Nutrition for adults.

Based on indications, other indications, followed by cancer care accounted for the largest share in terms of revenue in 2020. The increasing prevalence of cancer and other health conditions associated with cancer is likely to promote market growth. For instance, according to GLOBOCON 2020, there were around 19.3 million new cases of cancer worldwide in 2020. Europe accounted for about 23.4% of total cancer cases and Asia had the highest population suffering from cancer, which was about 60%.

In 2020, based on end user, the homecare segment accounted for the highest revenue share in the market and this segment is projected to witness the fastest CAGR over the forecast period. The increasing number of patients that receive home enteral feeding due to growing awareness about complete and balanced nutrition is one of the key factors contributing to the growth of this segment. For instance, according to a recent survey conducted in the U.K., there were 187 patients on home enteral tube feeding out of the total 257 patients. This suggested that approximately 72% of patients were on home enteral tube feeding.

North America dominated the market with a revenue share of 29.7% in 2020 owing to the growing burden of chronic diseases such as diabetes, cancer, and other neurological conditions. Furthermore, increasing preference for home-based enteral therapy has decreased the number of patient visits to hospitals and clinics. In addition, increasing malnutrition is expected to further boost the demand for enteral feeding formulas in this region.

In addition, the rising number of COVID-19 cases in various geographies coupled with the large geriatric population, susceptible to various health conditions, are among the factors contributing to the growth of the market. For instance, according to an article published in Europe PMC in 2020, enteral nutrition is generally preferred over parenteral nutrition for COVID-19 patients admitted to the ICUs. In addition, it should be provided within 48 hours of admission. Hence, such instances signify increasing adoption of enteral feeding formulas during the pandemic.

Enteral Feeding Formulas Market Report Highlights

• The market is anticipated to grow over the forecast period owing to the growing prevalence of chronic diseases and the rise in preterm births

• The standard formulas segment dominated the market in 2020, owing to the availability of a wide variety of standard formulas coupled with increased demand for low-cost nutrient formulations

• The intermittent feeding flow segment dominated the market in 2020, owing to better tolerance in patients shown by intermittent flow as compared to bolus feeding

• Adults accounted for the largest revenue share in the market in 2020 owing to the rising adoption of tube feeds in the adults and the availability of a large number of tube feeds or products for adults on the commercial level

• Other indications followed by cancer care accounted for the largest share in terms of revenue in 2020. The increasing prevalence of cancer and other health conditions associated with cancer is likely to promote market growth

• The homecare segment accounted for the highest revenue share in the market owing to the rising number of patients that receive home enteral feeding due to growing awareness about complete and balanced nutrition

• North America dominated the market with a revenue share of 29.7% in 2020 owing to the growing burden of chronic diseases such as diabetes, cancer, and other neurological conditions

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definition
1.3 Research Methodology
1.3.1 Information Procurement
1.3.1.1 Purchased database:
1.3.1.2 GVR’s internal database
1.3.2 Primary Research:
1.4 Research Scope and Assumptions
1.5 List to Data Sources
Chapter 2 Executive Summary
2.1 Global Enteral Feeding Formulas Market Outlook
2.2 Global Enteral Feeding Formulas Market Segment Outlook
2.3 Global Enteral Feeding Formulas Market Competitive Insight
2.4 Global Enteral Feeding Formulas Snapshot
Chapter 3 Global Enteral Feeding Formulas Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.1.1 Nutritional Supplements Market
3.1.1.1 Medical Foods Market
3.1.2 Related/ancillary market outlook
3.1.2.1 Parenteral Nutrition market
3.1.2.2 Enteral Feeding Devices Market
3.2 Penetration and Growth Prospect Mapping
3.3 Industry Analysis
3.3.1 User Perspective Analysis
3.3.1.1 Consumer behavior analysis
3.3.1.2 Market influencer analysis
3.3.2 Key End users
3.4 Technology Outlook
3.4.1 Technology timeline
3.5 Regulatory Framework
3.5.1 Reimbursement framework
3.5.2 Standards & compliance
3.5.3 Safety
3.6 Market Dynamics
3.6.1 Market Driver Analysis
3.6.1.1 Rising Geriatric Population
3.6.1.2 Growing prevalence of chronic diseases
3.6.1.3 Shifting trend towards Consumption of disease specific formulas
3.6.1.4 Growing demand for neonatal and preterm enteral feeding
3.6.2 Market Restraint Analysis
3.6.2.1 Lack of awareness amongst the medical community
3.6.2.2 Improper categorization of clinical nutritions
3.7 Industry Challenges
3.7.1 Complications associated with small – bore connectors
3.7.2 Risks associated with enteral feeding
3.8 Global Enteral Feeding Formulas Market Analysis Tools
3.8.1 Industry Analysis – Porter’s
3.8.1.1 Bargaining power of the suppliers
3.8.1.2 Bargaining power of the buyers
3.8.1.3 Threats of substitution
3.8.1.4 Threats from new entrants
3.8.1.5 Competitive rivalry
3.8.2 PESTEL Analysis
3.8.2.1 Political landscape
3.8.2.2 Economic and Social landscape
3.8.2.3 Technology landscape
3.8.2.4 Legal landscape
3.9 Major Deals & Strategic Alliances Analysis
3.9.1 Mergers & Acquisitions
3.9.2 Market Entry Strategies
3.9.3 Product Recalls
3.10 Impact of COVID-19 on Enteral Feeding Formulas Market
Chapter 4 Global Enteral Feeding Formula Market: Competitive Analysis
4.1 Recent Developments & Impact Analysis, By Key Market Participants
4.2 Company/Competition Categorization (Key innovators, market leaders, emerging players)
4.3 Key customers
4.4 Vendor Landscape
4.4.1 Key company Market share analysis, 2020
4.5 Public and Private Companies
4.5.1 Company Market Position Analysis
4.5.2 Company Market ranking by region
4.5.3 Regional map
Chapter 5 Global Enteral Feeding Formulas Market: Product Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Global Enteral Feeding Formulas Market: Product Market Share Analysis, 2020 and 2028
5.3 Standard formula
5.3.1 Standard formula market estimates and forecasts, 2014 – 2028 (USD Million)
5.4 Disease – specific formula
5.4.1 Disease – specific formula market estimates and forecasts, 2014 – 2028 (USD Million)
Chapter 6 Global Enteral Feeding Formulas Market: Flow Type Estimates & Trend Analysis
6.1 Definitions & Scope
6.2 Global Enteral Feeding Formulas Market: Flow Type Market Share Analysis, 2020 and 2028
6.3 Intermittent feeding flow
6.3.1 Intermittent feeding flow market estimates and forecasts, 2014 – 2028 (USD Million)
6.4 Continuous feeding flow
6.4.1 Continuous feeding flow market estimates and forecasts, 2014 – 2028 (USD Million)
Chapter 7 Global Enteral Feeding Formulas Market: Stage Estimates & Trend Analysis
7.1 Definitions & Scope
7.2 Global Enteral Feeding Formulas Market: Stage Market Share Analysis, 2020 and 2028
7.3 Adults
7.3.1 Adults market estimates and forecasts, 2014 – 2028 (USD Million)
7.4 Pediatrics
7.4.1 Pediatrics market estimates and forecasts, 2014 – 2028 (USD Million)
Chapter 8 Global Enteral Feeding Formulas Market: Indication Estimates & Trend Analysis
8.1 Definitions & Scope
8.2 Global Enteral Feeding Formulas Market: Indication Market Share Analysis, 2020 and 2028
8.3 Alzheimer’s
8.3.1 Alzheimer’s market estimates and forecasts, 2014 – 2028 (USD Million)
8.4 Nutrition deficiency
8.4.1 Nutrition deficiency market estimates and forecasts, 2014 – 2028 (USD Million)
8.5 Cancer care
8.5.1 Cancer care market estimates and forecasts, 2014 – 2028 (USD Million)
8.6 Diabetes
8.6.1 Diabetes market estimates and forecasts, 2014 – 2028 (USD Million)
8.7 Chronic kidney diseases
8.7.1 Chronic kidney diseases market estimates and forecasts, 2014 – 2028 (USD Million)
8.8 Orphan diseases
8.8.1 Orphan diseases market estimates and forecasts, 2014 – 2028 (USD Million)
8.9 Dysphagia
8.9.1 Dysphagia market estimates and forecasts, 2014 – 2028 (USD Million)
8.10 Pain management
8.10.1 Pain management market estimates and forecasts, 2014 – 2028 (USD Million)
8.11 Malabsorption/GI disorder/diarrhea
8.11.1 Malabsorption/GI disorder/diarrhea market estimates and forecasts, 2014 – 2028 (USD Million)
8.12 Others
8.12.1 Others market estimates and forecasts, 2014 – 2028 (USD Million)
Chapter 9 Global Enteral Feeding Formulas Market: End – user Estimates & Trend Analysis
9.1 Definitions & Scope
9.2 Global Enteral Feeding Formulas Market: End – user Market Share Analysis, 2020 and 2028
9.3 Hospitals
9.3.1 Hospitals market estimates and forecasts, 2014 – 2028 (USD Million)
9.3.2 Cardiology
9.3.2.1 Cardiology market estimates and forecasts, 2014 – 2028 (USD Million)
9.3.3 Neurology
9.3.3.1 Neurology market estimates and forecasts, 2014 – 2028 (USD Million)
9.3.4 Critical care (ICU)
9.3.4.1 Critical care (ICU) market estimates and forecasts, 2014 – 2028 (USD Million)
9.3.5 Oncology
9.3.5.1 Oncology market estimates and forecasts, 2014 – 2028 (USD Million)
9.4 Home care
9.4.1 Home care market estimates and forecasts, 2014 – 2028 (USD Million)
Chapter 10 Global Enteral Feeding Formulas Market: Regional Estimates & Trend Analysis, By Product, Flow Type, Stage, Indication and End User
10.1 Global Enteral Feeding Formulas Market: Regional Movement Analysis
10.2 North America
10.2.1 North America enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.2.2 U.S.
10.2.2.1 U.S. enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.2.3 Canada
10.2.3.1 Canada enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.3 Europe
10.3.1 Europe enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.3.2 Germany
10.3.2.1 Germany enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.3.3 U.K.
10.3.3.1 U.K. enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.3.4 France
10.3.4.1 France enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.3.5 Italy
10.3.5.1 Italy enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.3.6 Spain
10.3.6.1 Spain enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.3.7 Russia
10.3.7.1 Russia enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.4 Asia Pacific
10.4.1 Asia Pacific enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.4.2 Japan
10.4.2.1 Japan enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.4.3 China
10.4.3.1 China enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.4.4 India
10.4.4.1 India enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.4.5 Australia
10.4.5.1 Australia enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.4.6 New Zealand
10.4.6.1 New Zealand enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.4.7 Singapore
10.4.7.1 Singapore enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.4.8 South Korea
10.4.8.1 South Korea enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.5 Latin America
10.5.1 Latin America enteral market estimates and forecasts, by Product, Flow Type, and service type, 2014 – 2028 (USD Million)
10.5.2 Brazil
10.5.2.1 Brazil enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.5.3 Mexico
10.5.3.1 Mexico enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.5.4 Argentina
10.5.4.1 Argentina enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.6 MEA
10.6.1 MEA enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.6.2 South Africa
10.6.2.1 South Africa enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.6.3 Saudi Arabia
10.6.3.1 Saudi Arabia enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
10.6.4 UAE
10.6.4.1 UAE enteral feeding formulas market estimates and forecasts, by product, flow type, stage, indication and end user 2014 – 2028 (USD Million)
Chapter 11 Competitive Landscape
11.1 Danone
11.1.1 Company overview
11.1.2 Financial performance
11.1.3 Product benchmarking
11.1.4 Strategic initiatives
11.2 Nestle Nutrition
11.2.1 Company overview
11.2.2 Financial performance
11.2.3 Product benchmarking
11.2.4 Strategic initiatives
11.3 Abbott Nutrition
11.3.1 Company overview
11.3.2 Financial performance
11.3.3 Product benchmarking
11.3.4 Strategic initiatives
11.4 Mead Johnson & Company, LLC
11.4.1 Company overview
11.4.2 Financial performance
11.4.3 Product benchmarking
11.4.4 Strategic initiatives
11.5 Fresenius Kabi AG
11.5.1 Company overview
11.5.2 Financial performance
11.5.3 Product benchmarking
11.5.4 Strategic initiatives
11.6 Meiji Holdings Co., Ltd.
11.6.1 Company overview
11.6.2 Financial performance
11.6.3 Product benchmarking
11.6.4 Strategic initiatives
11.7 Victus
11.7.1 Company overview
11.7.2 Financial performance
11.7.3 Product benchmarking
11.7.4 Strategic initiatives
11.8 List of Other Companies

List of Tables

Table 1 List of conferences, 2016 - 2020
Table 2 North America geriatric population estimates and forecasts, by country, 2014 - 2028 (USD Million)
Table 3 Europe geriatric population estimates and forecasts, by country, 2014 - 2028 (USD Million)
Table 4 Asia Pacific geriatric population estimates and forecasts, by country, 2014 - 2028 (USD Million)
Table 5 Latin America geriatric population estimates and forecasts, by country, 2014 - 2028 (USD Million)
Table 6 MEA geriatric population estimates and forecasts, by country, 2014 - 2028 (USD Million)
Table 7 Number of preterm birth and proportion of global preterm births, 2014
Table 8 North America enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 9 North America enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 10 North America enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 11 North America enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 12 North America enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 13 North America enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 14 U.S. enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 15 U.S. enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 16 U.S. enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 17 U.S. enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 18 U.S. enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 19 U.S. enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 20 Canada enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 21 Canada enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 22 Canada enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 23 Canada enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 24 Canada enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 25 Canada enteral feeding formulas market for hospitals, by department,2014 - 2028 (USD Million)
Table 26 Europe enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 27 Europe enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 28 Europe enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 29 Europe enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 30 Europe enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 31 Europe enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 32 Germany enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 33 Germany enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 34 Germany enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 35 Germany enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 36 Germany enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 37 Germany enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 38 U.K. enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 39 U.K. enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 40 U.K. enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 41 U.K. enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 42 U.K. enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 43 U.K. enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 45 Spain enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 46 Spain enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 47 Spain enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 48 Spain enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 49 Spain enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 50 Spain enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 51 France enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 52 France enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 53 France enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 54 France enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 55 France enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 56 France enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 57 Italy enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 58 Italy enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 59 Italy enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 60 Italy enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 61 Italy enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 62 Italy enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 63 Russia enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 64 Russia enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 65 Russia enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 66 Russia enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 67 Russia enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 68 Russia enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 69 Asia Pacific enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 70 Asia Pacific enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 71 Asia Pacific enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 72 Asia Pacific enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 73 Asia Pacific enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 74 Asia Pacific enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 75 Japan enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 76 Japan enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 77 Japan enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 78 Japan enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 79 Japan enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 80 Japan enteral feeding formulas market for hospitals, by department, 2014 - 2028 (USD Million)
Table 81 China enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 82 China enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 83 China enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 84 China enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 85 China enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 86 China enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 87 Australia enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 88 Australia enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 89 Australia enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 90 Australia enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 91 Australia enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 92 Australia enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 93 New Zealand enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 94 New Zealand enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 95 New Zealand enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 96 New Zealand enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 97 New Zealand enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 98 New Zealand enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 99 India enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 100 India enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 101 India enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 102 India enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 103 India enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 104 India enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 105 Singapore enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 106 Singapore enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 107 Singapore enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 108 Singapore enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 109 Singapore enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 110 Singapore enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 111 South Korea enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 112 South Korea enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 113 South Korea enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 114 South Korea enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 115 South Korea enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 116 South Korea enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 117 Latin America enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 118 Latin America enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 119 Latin America enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 120 Latin America enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 121 Latin America enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 122 Latin America enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 123 Brazil enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 124 Brazil enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 125 Brazil enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 126 Brazil enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 127 Brazil enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 128 Brazil enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 129 Mexico enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 130 Mexico enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 131 Mexico enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 132 Mexico enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 133 Mexico enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 134 Mexico enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 135 Argentina enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 136 Argentina enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 137 Argentina enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 138 Argentina enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 139 Argentina enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 140 Argentina enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 141 MEA enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 142 MEA enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 143 MEA enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 144 MEA enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 145 MEA enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 146 MEA enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 147 South Africa enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 148 South Africa enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 149 South Africa enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 150 South Africa enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 151 South Africa enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 152 South Africa enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 153 Saudi Arabia enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 154 Saudi Arabia enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 155 Saudi Arabia enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 156 Saudi Arabia enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 157 Saudi Arabia enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 158 Saudi Arabia enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 159 UAE enteral feeding formulas market, by product, 2014 - 2028 (USD Million)
Table 160 UAE enteral feeding formulas market, by flow type, 2014 - 2028 (USD Million)
Table 161 UAE enteral feeding formulas market, by stage, 2014 - 2028 (USD Million)
Table 162 UAE enteral feeding formulas market by indication, 2014 - 2028 (USD Million)
Table 163 UAE enteral feeding formulas market by end user, 2014 - 2028 (USD Million)
Table 164 UAE enteral feeding formulas market for hospitals, by department 2014 - 2028 (USD Million)
Table 165 List of other key players

List of Figures

Fig. 1 Enteral feeding formula market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Enteral Feeding Formula market summary, 2020 (USD Million)
Fig. 6 Enteral feeding formula market trends & outlook
Fig. 7 Parent market analysis, 2020
Fig. 8 Timeline for new ENFit Connectors
Fig. 9 Penetration & growth prospect mapping
Fig. 10 Consumer decision-making process
Fig. 11 Evolution of clinical nutrition
Fig. 12 Market driver analysis (Current & future impact)
Fig. 13 Global population growth, by age-group, 2012 - 2020 (Million)
Fig. 14 Global percentage of population, by age group, 2000 and 2050
Fig. 15 Increase in the number of people with chronic conditions in the U.S., 1995 - 2030 (in million)
Fig. 16 Percentage of U.S. adults and healthcare spending, by number of chronic diseases
Fig. 17 Preterm birth by gestational age and region for 2014
Fig. 18 Market restraint analysis (Current & future impact)
Fig. 19 Enteral Feeding Formula Market - PESTLE analysis
Fig. 20 Industry analysis - Porter’s
Fig. 21 Enteral feeding formula market share analysis, 2019/20
Fig. 22 Heat map analysis, 2020
Fig. 23 Company market position, by region, 2020
Fig. 24 Regional network map
Fig. 25 Enteral feeding formula market, Product outlook: key takeaways, USD Million
Fig. 26 Enteral feeding formula market: Product movement analysis, 2020 & 2028 (USD Million)
Fig. 27 Standard formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 28 Disease-specific formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 29 Enteral feeding formula market, Flow type outlook: key takeaways, USD Million
Fig. 30 Enteral feeding formula market: Flow type movement analysis, 2020 & 2028 (USD Million)
Fig. 31 Intermittent feeding flow market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 32 Continuous feeding flow market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 33 Enteral feeding formulas market, Stage outlook: key takeaways, USD Million
Fig. 34 Enteral feeding formula market: Stage movement analysis, 2020 & 2028 (USD Million)
Fig. 35 Adults feeding flow market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 36 Pediatrics market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 37 Enteral feeding formulas market: Indication outlook: key takeaways, USD Million
Fig. 38 Enteral feeding formula market: Indication movement analysis, 2020 & 2028 (USD Million)
Fig. 39 Alzheimer’s market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 40 Nutrition deficiency market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 41 Cancer care market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 42 Diabetes market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 43 Chronic kidney diseases market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 44 Orphan diseases market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 45 Dysphagia market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 46 Pain management market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 47 Malabsorption/GI disorder/diarrhea market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 48 Others market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 49 Enteral feeding formulas market, End-use outlook: key takeaways, USD Million
Fig. 50 Enteral feeding formula market: End-use movement analysis, 2020 & 2028 (USD Million)
Fig. 51 Hospitals market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 52 Hospitals market estimates and forecasts, by Cardiology, 2014 - 2028 (USD Million)
Fig. 53 Hospitals market estimates and forecasts, by Neurology, 2014 - 2028 (USD Million)
Fig. 54 Hospitals market estimates and forecasts, by Critical care (ICU), 2014 - 2028 (USD Million)
Fig. 55 Hospitals market estimates and forecasts, by Oncology, 2014 - 2028 (USD Million)
Fig. 56 Hospitals market estimates and forecasts, by Others, 2014 - 2028 (USD Million)
Fig. 57 Regional marketplace: Key takeaways
Fig. 58 Enteral feeding formula market: Regional movement analysis, 2020 & 2028 (USD Million)
Fig. 59 North America enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 60 U.S. enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 61 Canada enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 62 Europe enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 63 U.K. enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 64 Germany enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 65 France enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 66 Spain enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 67 Italy Enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 68 Russia enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 69 Asia Pacific enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 70 Japan enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 71 China enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 72 Australia enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 73 New Zealand enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 74 India enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 75 South Korea enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 76 Singapore enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 77 Latin America enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 78 Brazil enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 79 Mexico enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 80 Argentina enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 81 MEA enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 82 South Africa enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 83 South Africa enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)
Fig. 84 UAE enteral feeding formula market estimates and forecasts, 2014 - 2028 (USD Million)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の経腸栄養剤市場2021-2028:製品別、フロータイプ別、段階別(成人、小児)、疾患別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆